Wound Treatments in Russia - Market Research Reports

Printer Friendly

Printed from http://www.researchandmarkets.com/reports/224759

Wound Treatments in Russia

Description:

The Wound Treatments in Russia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: sticking plasters, other wound treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?
- Get a detailed picture of the wound treatments industry
- Identify growth sectors and factors driving change
- Understand the competitive environment, the market’s major players and leading brands
- Use five-year forecasts to assess how the market is predicted to develop

Contents:

Wound Treatments in Russia
Euromonitor International
November 2009
List of Contents and Tables
Executive Summary
Economic Crisis Since Autumn of 2008
New Registration Rules Lead To Cuts in Imports
Generics Continues To Be Predominant in Russia
Domestic Pharmaceutical Giant Among the Market Leaders
Opportunities for Growth
Key Trends and Developments
Economic Crisis Corrects Development of OTC Healthcare Market
Self-medication
Russian Federation Pharmaceutical Sector Development Strategy To 2020
Private Label Gains Ground
Extensive Growth for Retailer Chains
City Key Trends and Developments
Moscow
St Petersburg
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
Market Data
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 Sales of OTC Healthcare by City: Value 2003-2008
Table 6 Sales of OTC Healthcare by City: % Value Growth 2003-2008
Table 7 OTC Healthcare Company Shares by Value 2004-2008
Table 8 OTC Healthcare Brand Shares by Value 2005-2008
Table 9 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 10 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 11 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 12 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Table 13 Forecast Sales of OTC Healthcare by City: Value 2008-2013
Table 14 Forecast Sales of OTC Healthcare by City: % Value Growth 2008-2013
Appendix
OTC Registration and Classification
De-listing Or De-reimbursement
Advertising
Packaging and Labelling
Production
Distribution
Vitamins & Dietary Supplements Registration and Classification
Generics
Switches
Summary 1 OTC Healthcare Switches 2007
Definitions
Summary 2 Research Sources
Akrikhin Oao
Strategic Direction
Key Facts
Summary 3 Akrikhin OAO: Key Facts
Summary 4 Akrikhin OAO: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 Akrikhin OAO: Competitive Position 2008
Berlin Chemie Russia
Strategic Direction
Key Facts
Summary 6 Berlin Chemie/ Menarini Group: Key Facts
Company Background
Production
Competitive Positioning
Summary 7 Berlin Chemie Russia : Competitive Position 2008
GlaxoSmithKline Plc
Strategic Direction
Key Facts
Summary 8 GlaxoSmithKline PLC: Key Facts
Company Background
Production
Competitive Positioning
Summary 9 GlaxoSmithKline PLC: Competitive Position 2008
Novartis AG
Strategic Direction
Key Facts
Summary 10 Novartis AG : Key Facts
Summary 11 Novartis AG: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 12 Novartis AG: Competitive Position 2008
Pharmstandard Group
Strategic Direction
Key Facts
Summary 13 Pharmstandard Group: Key Facts
Summary 14 Pharmstandard Group: Operational Indicators
Company Background
Production
Summary 15 Pahrmstandard Group : Production Statistics 2007
Competitive Positioning
Summary 16 Pharmstandard: Competitive Position 2008
Valenta Oao
Strategic Direction
Key Facts
Summary 17 Valenta OAO: Key Facts
Summary 18 Valenta OAO: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 19 Otechestvennye Lekarstva Holding: Competitive Position 2008
Veropharm Zao
Strategic Direction
Key Facts
Summary 20 Veropharm ZAO: Key Facts
Summary 21 Veropharm ZAO: Operational Indicators
Company Background
Production
Summary 22 Veropharm ZAO: Production Statistics 2006
Competitive Positioning
Summary 23 Veropharm ZAO: Competitive Position 2008
Trends
Sector Data
Table 15 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 16 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 17 Wound Treatments Company Shares by Value 2004-2008
Table 18 Wound Treatments Brand Shares by Value 2005-2008
Table 19 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 20 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013

Summary:

Most Russian manufacturers produce generics
Currently, most Russian manufacturers produce pharmaceutical products whose patents expired 15-20 years ago. They are usually called "generics". Currently, a significant number of local producers manufacture identical products. Russian companies are unable to finance the multi-billion dollar research programmes that international pharmaceutical giants are capable of conducting. This explains the significant shares held by multinationals in Russia, as the average Russian citizen is keen on buying products provided they can afford them. Alternatively they can purchase local generic alternatives of new branded drugs, or else products produced by companies of the former Soviet bloc.

Companies Mentioned

Companies Mentioned Include: - KRKA - Gedeon Richter - Nizhpharm - Nycomed - Servier - Berlin-Chemie - Pfizer - Akrikhin - Yamanouchi - Bayer - LEK - Aventis - UPSA - Pharmstandard (ex. ICN) - R. Bittner - Pliva - Bryntsalov - Natur Product - Verofarm - UPSA Russia - Krka Pharma OOO - GlaxoSmithKline Healthcare ZAO - Novartis Consumer Health SA - Galena as/ Norton Healthcare Ltd - Balkanpharma Holding AD - Berlin Chemie Russia - Aventis Pharma (Russia) - Pharmstandard Group - Unipharm Russia - Akrikhin OAO - Sagmel Inc - Ufavita OAO - Nycomed Russia-CIS - Roche Moscow Ltd - Nizhpharm AO - Pfizer Inc - Lek Pharmaceuticals dd - GlaxoSmithKline Plc - Unique Pharmaceutical Laboratories - Verofarm ZAO - Altayvitaminy CJSC - Neways Inc - ICN Polfa Rzeszow SA - Merz & Co GmbH & Co - Minskintercaps SP - Leovit-Nutrio OOO - Beaufour-Ipsen SA - Pliva dd - Biogal-Teva Pharma Rt - Krewel Meuselbach GmbH - Ecco Plus OOO - Eurosirel srl - Chemopharma as - Asta Medica AG - Olainfarm AS - Queisser Pharma GmbH & Co - Bausch & Lomb European Pharmaceuticals - Hartmann AG, Paul - Dalkhimpharm OAO - Egis AO - Ferrosan A/S - Schering-Plough Central East AG - Irwin Naturals - Beaufour-Ipsen International - Boehringer Ingelheim Pharma GmbH & Co KG - Tatchimfarmpreparati KPNFO - Janssen Pharmaceutica NV - Yamanouchi Europe BV - Bayer AO - Moskchimpharmpreparaty FGUP - Walsh Pharmaceuticals - Akrichin - Otechestvennye Lekarstva - Naturwaren Ohg Dr Peter Theiss - Hexal AG - Bryntsalov - A ZAO - Warner-Lambert Russia - Johnson & Johnson (Russia) Ltd - Novartis AG - Inat Pharma OOO - Boots Healthcare International - Bional International BV - Richard Bittner GmbH - Evalar ZAO - Ranbaxy Laboratories Ltd - Richter Gedeon Rt - Mars Russia OOO - Nature's Sunshine Products Inc - Warszawa ZF Polfa - Glenmark Pharmaceuticals Ltd - BioKontur ZAO - ICN Pharmaceutical Inc - Novosibkhimpharm AOOT - Bristol-Myers Squibb Co - Belmedpreparaty JSC - Slovakofarma as - ADH Health Products Inc

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/224759

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.